Maryland’s biopharmaceutical companies research and develop new treatments and cures that improve patient health while also contributing to U.S. economic health. These companies employ highly skilled union construction workers to build state-of-the-art research and manufacturing facilities to ensure infrastructure is built to exacting standards.

Construction Employment

Union Labor & Earnings, 2015-20

Pharmaceutical & Biotech

3.4

million

Labor Hours Demanded

(14 trades, installation, and maintenance)

598,832

Union Labor Hours (est.)

(State union% in non-residential = 17.5%)

$19

million

Total Union Earnings (est.)

(Union hours times average wage)

Maryland Construction Labor Hours by Trade

Pharmaceutical & Biotech, 2015-20

-->

33,150

Installation

9,109

Maintenance

42,259

Total hours

Largest Construction Projects

Pharmaceutical & Biotech Manufacturing, 2015-20

MedImmune LLC

660 Medimmune Ct, Frederick, MD 21703, USA

Frederick Manufacturing Center (FMC) Biologics Plant Building 636 Expansion

Frederick, MD

$250,000,000

2015-2017

Emergent BioSolutions Incorporated

5901 E Lombard St, Baltimore, MD 21224, USA

Baltimore Anthrax and Flu Vaccine Plant Expansion

Baltimore, MD

$150,000,000

2015-2018

Emergent BioSolutions Incorporated

5901 E Lombard St, Baltimore, MD 21224, USA

Baltimore Bayview Vaccine Bulk Covid-19 Plant Reno/Equipment Add

Baltimore, MD

$150,000,000

2020-2022

GlaxoSmithKline PLC

9911 Belward Campus Dr, Rockville, MD 20850, USA

Rockville Biopharmaceutical Benlysta Raxibacumab Autoimmune Plant Retrofit

Rockville, MD

$139,000,000

2017-2019

Paragon Bioservices, a Catalent Pharma Company

7565 Harmans Rd, Harmans, MD 21077, USA

Baltimore Gene Therapy CDMO Campus Single-Use System 7565 Harman Rd Expansion

Baltimore, MD

$130,000,000

2020-2022

Kite Pharma Incorporated

Ijamsville, MD, USA

Ijamsville (Urbana) Grassroot Chimeric Anitgen Receptor T (Car T) Plant

Ijamsville, MD

$105,000,000

2019-2022

United Therapeutics Corporation

United Therapeutics Silver Spring Campus, 1040 Spring St, Silver Spring, MD 20910, USA

Silver Spring Biologics Liquid Drug Substance Manufacturing Unit Addition

Silver Spring, MD

$85,000,000

2017-2018

Paragon Bioservices, a Catalent Pharma Company

801 W Baltimore St, Baltimore, MD 21201, USA

Baltimore Brownfield Cell/Gene Therapy & Vaccines Clinical Scale CDMO Plant

Baltimore, MD

$80,000,000

2018-2019

United Therapeutics Corporation

Silver Spring Biomedical Product Research Unisphere Building Expansion

Silver Spring, MD

$65,000,000

2016-2018

Novavax Incorporated

21 Firstfield Rd, Gaithersburg, MD 20878, USA

Gaithersburg Brownfield Pilot Covid-19 Vaccine Plant Conversion Phase 2

Gaithersburg, MD

$55,000,000

2020-2021

MedImmune LLC

Frederick Manufacturing Center (FMC) Biologics Plant Building 636 Expansion

Frederick, MD

Location

$250,000,000

Project Value

2015-2017

Years

Take Action

Share the study results and spread the word about the connection between the biopharmaceutical industry and union construction workers in Maryland!

You may be surprised by the connection between Maryland's biopharmaceutical industry and union labor. A new study finds that from 2015-2020 America’s biopharmaceutical companies invested $1.7 billion dollars in infrastructure in the state, supporting 598,832 union labor hours. View Maryland's labor-industry profile here: https://bit.ly/2G33fVy

Maryland's pharmaceutical companies and the building trades unions have a surprising relationship - a new study finds that from 2015-2020 biopharmaceutical companies invested $1.7 billion in infrastructure in the state, supporting 598,832 union labor hours. View Maryland's labor-industry profile here: https://bit.ly/2G33fVy